Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to include a new facility name and location details, along with a list of relevant publications, while removing several location-related terms and previous MedlinePlus topics.SummaryDifference8%
- Check25 days agoChange DetectedThe web page has been updated to reflect a new study on subretinal surgical delivery and the activity of OpRegen, with changes in the study's timeline, locations, and eligibility criteria. Notably, the number of study locations has increased from 9 to 11, and the study dates have been updated to August 2025.SummaryDifference21%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.